NOVALYTELABS
NOVALYTEGHRP-210mgLyophilised powderPurity ≥ 99% HPLCRESEARCH USE ONLY
In stock COA DOCUMENT SLOT-25%
Growth Research

GHRP-2

Synthetic hexapeptide growth hormone secretagogue studied for GH release, appetite regulation, and GHSR-1a signalling.

Growth Hormone BoostAppetite StimulationMuscle GrowthFat LossRecovery
10mg
€59.90€44.90-25%
Limited offer — prices slashed on this compound. Pay with crypto for an extra 10% off.
Research catalogueLaboratory-use positioning
Batch documentationBatch certificate supplied with order
Order trackingFrom payment to dispatch

Product information

CompoundGHRP-2
Presentation10mg vial
CategoryGrowth Research
AvailabilityIn stock
Batch COACertificate supplied with order
€59.90€44.9025%

You save €15.00 on this presentationan extra 10% off when you pay with crypto.

VIEW CART

For research use only. Not for human consumption, diagnostic, therapeutic or veterinary use.

Overview

GHRP-2 (Growth Hormone Releasing Peptide-2, pralmorelin) is a synthetic hexapeptide GH secretagogue and one of the most potent compounds in the GHRP family. Developed in the 1990s by Bowers and Momany, it was instrumental in the discovery and characterisation of the ghrelin receptor (GHSR-1a) before the endogenous ligand ghrelin was identified. GHRP-2 remains a reference compound in growth hormone research, widely used for its robust and reproducible GH-releasing effects in both preclinical and clinical pharmacology studies.

Mechanism of Action

GHRP-2 activates GHSR-1a on pituitary somatotrophs through a Gq-coupled mechanism involving phospholipase C activation, IP3-mediated calcium release from intracellular stores, and calcium influx through L-type channels. This dual calcium signal triggers GH granule exocytosis. GHRP-2 also acts at the hypothalamic level to stimulate GHRH-releasing neurons and suppress somatostatin release, creating a dual amplification of GH secretion. Unlike ipamorelin, GHRP-2 has notable effects on cortisol, ACTH, and prolactin, reflecting broader activation of hypothalamic pathways including appetite-stimulating circuits.

Research Applications

  • GH secretagogue receptor characterisation research
  • Growth hormone dose-response and kinetics studies
  • Hypothalamic GHRH-somatostatin axis investigation
  • Appetite regulation and ghrelin pathway research
  • Comparative GHS selectivity profiling
FREE TOOL

Reconstitution calculator

Enter your reconstitution to get the draw volume for GHRP-2.

Syringe size
Concentration5.00 mg/ml
Draw volume0.050 ml
On the syringe5.0 units
Doses per vial40
5units

Pull the plunger to 5.0 units on a 1 ml U‑100 syringe0.050 ml · 5.00 mg/ml · 40 doses per vial

0102030405060708090100
Best fit for this drawInsulin Syringes 0.3 ml0.050 ml fits the barrel, and the smallest barrel that holds a draw reads most precisely.View syringe

Concentration = peptide mass ÷ water volume. Unit readings assume U-100 insulin syringes, graduated 100 units per millilitre. For laboratory calculation only — not dosing guidance.